Lifesciences – Medgate Today

Home / Posts Tagged "Lifesciences"

Zydus receives final approval from the USFDA for Micafungin for Injection

October 31, 2022

5:25 am

Zydus Lifesciences Limited (formerly known as Cadila Healthcare Limited) has received final approval from the United States Food and Drug Administration (USFDA) to market Micafungin for Injection, 50 mg/vial and 100 mg/vial, single-dose vials (USRLD: Mycamine®). Micafungin for Injection is indicated to treat variety of fungal infections. It

POST TAGS:

Over 80% newly diagnosed diabetic patients in India have at least one cholesterol abnormality: India Diabetes Study reveals

April 9, 2022

8:03 am

News Update

admin

Lipid abnormalities were determined basis the mentioned cut-offs recommended by LAI (Lipid Association of India): HDL (High-density lipoprotein) < 40 mg/dL for males HDL<50 mg/dL for females, LDL (Low-density lipoprotein) ≥130 mg/dL, total cholesterol ≥200 mg/dL, TG (Triglycerides) ≥150 m/dL The findings of this

POST TAGS:

Dr A. G. Unnikrishnan Dr R. K. Sahay dyslipidaemia Endocrinology Lifesciences Mr Manish Kapoor Osmania General Hospital Over 80% newly diagnosed diabetic patients in India have at least one cholesterol abnormality: India Diabetes Study reveals

Zydus receives final approval from the USFDA for Micafungin for Injection

POST TAGS:

Over 80% newly diagnosed diabetic patients in India have at least one cholesterol abnormality: India Diabetes Study reveals

POST TAGS:

FIND US

ADDRESS

FOLLOW US ON SOCIAL MEDIA